跳至主要内容
临床试验/NCT00233922
NCT00233922已完成2 期

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

National University Hospital, Singapore2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2004年7月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
80
试验地点
2
主要终点
visual acuity

研究概览

简要总结

Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months. CT scan of the orbits are performed preop, 6 months & 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.

详细描述

Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months. CT scan of the orbits are performed preop, 6 months & 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age: 20 - 70 years facial trauma with orbital fractures

排除标准

  • No other coexistent conditions eg. diabetes, heart disease, etc

结局指标

主要结局

visual acuity

Enophthalmos

Diplopia

Cosmetic appearance

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验